FDA Inspection 1263860 — Athena Bioscience, LLC
The FDA completed an inspection of Athena Bioscience, LLC on Feb 21, 2025 in Watkinsville, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 21, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Watkinsville, GA (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)